InternationalUSRemember you can easily switch between MIP US and MIP International at any time

AstraZeneca ruling could mean more competition cases

James Nurton, London

The European Commission could be more likely to take action against IP owners for blocking competition, after a court today endorsed its AstraZeneca decision

The EU General Court broadly upheld the European Commission’s 2005 decision that AstraZeneca had abused its dominant position by preventing the marketing of generic rivals to its blockbuster drug Losec.

It agreed with the Commission that the pharmaceutical...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here


Most read articles